Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pathologie (Heidelberg, Germany)|April 3, 2025
[Molecular pathology in non-small-cell lung cancer: current and emerging biomarkers]Helen Pasternack, Jutta Kirfel
Chest|July 26, 2018
An Unexpected Endobronchial Mass Appearing During BronchoscopyHelmut J F Salzer, Christiane Kuempers, Helen Pasternack, et al.
Scientific Reports|June 12, 2020
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulationRosemarie Krupar, Christian Watermann, Christian Idel, et al.
Cancers|April 23, 2022
Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMTAnna-Lena Lemster, Elisabeth Sievers, Helen Pasternack, et al.
Scientific Reports|November 28, 2023
Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumorsHelen Pasternack, Mirjam Polzer, Timo Gemoll, et al.
Human Pathology|February 5, 2017
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare eventsSebastian Huss, Helen Pasternack, Michaela Angelika Ihle, et al.
Scientific Reports|May 6, 2021
Identification of molecular signatures associated with early relapse after complete resection of lung adenocarcinomasHelen Pasternack, Christiane Kuempers, Mario Deng, et al.
Cancers|September 28, 2021
PD-L1 Dependent Immunogenic Landscape in Hot Lung Adenocarcinomas Identified by Transcriptome AnalysisJutta Kirfel, Christiane Charlotte Kümpers, Anke Fähnrich, et al.
NPJ Precision Oncology|June 7, 2018
<i>ALK</i><sup>G1269A</sup> mutation as a potential mechanism of acquired resistance to crizotinib in an <i>ALK</i>-rearranged inflammatory myofibroblastic tumorSebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune EvasionChristian Watermann, Helen Pasternack, Christian Idel, et al.
Pageof 2